Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of the Novel Drug Dimebon in Patients With Huntington's Disease (DIMOND)

This study has been completed.
Sponsor:
Collaborator:
Huntington Study Group
Information provided by (Responsible Party):
Medivation, Inc.
ClinicalTrials.gov Identifier:
NCT00497159
First received: July 3, 2007
Last updated: May 16, 2015
Last verified: May 2015